Infectious Disease

Payer Perspectives on Risk Stratification for CDI Recurrence

December 16th 2021, 2:20pm


Payer participants consider how they proactively risk stratify patients for clostridium difficile infection recurrence.

What We’re Reading: Moderna Vaccine Efficacy Reduced; Vaccine Mandate Revived; New Combo Against Breast Cancer

December 16th 2021, 2:16pm


Two doses of the Moderna COVID-19 vaccine have reduced efficacy against the Omicron variant; a federal appeals court reinstates the Biden administration’s health care worker vaccine mandate in 26 states; a new combination therapy may reduce breast cancer progression.

Bezlotoxumab Use in Patients at High Risk for CDI Recurrence

December 16th 2021, 2:00pm


A brief review of the role of bezlotoxumab therapy for patients at high risk for clostridium difficile infection recurrence.

Defining Value in Recurrent CDI

December 9th 2021, 2:20pm


An overview on how the cost of therapy for recurrent clostridium difficile infection may impact treatment planning.

Practical Considerations for Fidaxomicin Use in Recurrent CDI

December 9th 2021, 2:00pm


Focused discussion on the use of fidaxomicin for clostridium difficile infection, and possible barriers to the selection of this agent.

Dr Leslie Kantor on Responding to Misinformation About Flu Vaccines

December 3rd 2021, 10:00pm


Misinformation about flu vaccines must be dealt with immediately, according to Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health.

Payer Perspectives on Coverage Criteria for Clostridium Difficile Treatments

December 2nd 2021, 2:45pm


Payer participants break down how coverage criteria are determined for treatments for clostridium difficile infection.

Treatment Guidelines and Recommendations for C. Diff Infection

December 2nd 2021, 2:00pm


Shared insight on the differences between ACG and IDSA/SHEA treatment guidelines for patients with clostridium difficile infection.

Maternal STIs Linked With Increased Risk of Preterm Birth

November 29th 2021, 4:00pm


Results of a nationwide retrospective cohort study show maternal infection with syphilis, gonorrhea, or chlamydia was associated with an increased risk of preterm birth.

GAO Report: Policies to Incentivize Vaccine Development and Investment

November 24th 2021, 7:15pm


The report briefly explained the policy options that policymakers can use to help address challenges related to vaccine research and development, testing, and manufacturing, as well as the economic challenges related to vaccine development for infectious diseases.